Castle Biosciences (CSTL) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…

Castle Biosciences (CSTL) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 24, 2025 (21:35)

Sector: Healthcare

The share price of Castle Biosciences, Inc. (CSTL) now

Latest session on the 23rd of May for
Castle Biosciences, Inc. is positive
Trading Volume: 287463
Open: 15.76 /  High: 16.145 /  Low: 15.66
Current value: $16.1
What analysts predict: $35.89
52-week High/Low: $35.84 / $15.7
50-Day Moving Average: $19.33 — resistance level today
200-Day Moving Average: $26.34 — resistance level today

Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences stock price in 2025, 2026, 2027. How much will one Castle Biosciences share be worth in 2025 - 2027?

When should I take profit in Castle Biosciences stock? When should I record a loss on Castle Biosciences stock? What are analysts' forecasts for Castle Biosciences stock? What is the future of Castle Biosciences stock? We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.


Historical and forecast chart of Castle Biosciences stock

The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.

Long-term forecasts by years.

Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.

Trending Themes in the Healthcare Sector

Castle Biosciences daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 16.45 16.12 16.64 3.27
May 27 16.39 16.00 16.81 5.04
May 28 15.76 15.43 15.90 3.06
May 29 15.63 15.27 15.87 3.93
May 30 15.68 15.44 16.02 3.78
May 31 15.50 15.05 15.92 5.72
Jun 01 15.63 15.17 16.07 5.93
Jun 02 15.34 15.02 15.51 3.27
Jun 03 15.80 15.65 16.02 2.34
Jun 04 16.00 15.79 16.37 3.65
Jun 05 15.45 15.10 15.71 4.01
Jun 06 16.00 15.62 16.25 4.06
Jun 07 16.34 16.20 16.65 2.78
Jun 08 16.79 16.65 17.12 2.82
Jun 09 17.17 16.72 17.46 4.44
Jun 10 16.89 16.50 17.14 3.89
Jun 11 17.37 16.87 17.81 5.60
Jun 12 17.64 17.20 17.98 4.51
Jun 13 17.81 17.53 18.15 3.54
Jun 14 17.20 16.77 17.51 4.43
Jun 15 17.49 17.23 17.74 2.92
Jun 16 17.14 16.82 17.34 3.10
Jun 17 17.81 17.39 18.29 5.16
Jun 18 18.31 17.95 18.66 4.00
Jun 19 18.55 18.21 18.92 3.87
Jun 20 19.17 18.63 19.36 3.95
Jun 21 18.61 18.24 18.88 3.51
Jun 22 17.98 17.57 18.53 5.48
Jun 23 18.21 17.83 18.38 3.06
Jun 24 17.92 17.45 18.34 5.09

Castle Biosciences Daily Price Targets


Castle Biosciences Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $16.45.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 3.163%.
Pessimistic target level: 16.12
Optimistic target level: 16.64

Castle Biosciences Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $16.39.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 4.799%.
Pessimistic target level: 16.00
Optimistic target level: 16.81

Castle Biosciences Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $15.76.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 2.972%.
Pessimistic target level: 15.43
Optimistic target level: 15.90

Castle Biosciences Stock Forecast 05-29-2025.

Forecast target price for 05-29-2025: $15.63.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.781%.
Pessimistic target level: 15.27
Optimistic target level: 15.87

Castle Biosciences Stock Forecast 05-30-2025.

Forecast target price for 05-30-2025: $15.68.
Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 3.640%.
Pessimistic target level: 15.44
Optimistic target level: 16.02

Castle Biosciences Stock Forecast 05-31-2025.

Forecast target price for 05-31-2025: $15.50.
Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 5.415%.
Pessimistic target level: 15.05
Optimistic target level: 15.92

CSTL (CSTL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 16.63 15.60 18.14 13.99
Jul. 17.93 16.60 18.88 12.10
Aug. 16.85 15.74 17.56 10.35
Sep. 15.39 14.16 16.01 11.57
Oct. 15.73 14.50 16.39 11.55
Nov. 16.77 15.99 18.32 12.69
Dec. 16.32 15.45 17.39 11.17

Castle Biosciences forecast for this year


Castle Biosciences Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $16.6256. Pessimistic: $15.60. Optimistic: $18.14


Castle Biosciences Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $17.929. Pessimistic: $16.60. Optimistic: $18.88


Castle Biosciences Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $16.8497. Pessimistic: $15.74. Optimistic: $17.56


Castle Biosciences Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $15.3871. Pessimistic: $14.16. Optimistic: $16.01


Castle Biosciences Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $15.7318. Pessimistic: $14.50. Optimistic: $16.39


Castle Biosciences Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $16.7669. Pessimistic: $15.99. Optimistic: $18.32


Castle Biosciences Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $16.3209. Pessimistic: $15.45. Optimistic: $17.39



Castle Biosciences (CSTL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 17.30 15.39 18.66 17.53
Feb 18.25 16.59 19.99 17.00
Mar 17.48 16.09 18.46 12.86
Apr 16.16 14.42 17.65 18.33
May 14.40 13.57 15.46 12.25
Jun 14.84 13.59 15.61 12.91
Jul 15.65 14.38 17.14 16.11
Aug 15.04 13.79 16.42 16.02
Sep 15.39 14.42 16.88 14.55
Oct 15.05 13.76 15.81 12.93
Nov 15.95 15.20 17.74 14.35
Dec 16.67 16.09 17.72 9.22

Castle Biosciences (CSTL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 16.88 16.22 18.08 10.32
Feb 14.73 13.57 16.25 16.49
Mar 15.66 14.65 17.17 14.68
Apr 15.35 14.81 16.96 12.67
May 17.00 16.43 18.77 12.43
Jun 17.48 16.06 18.36 12.53
Jul 18.78 18.15 20.59 11.87
Aug 19.78 17.84 20.75 14.01
Sep 18.67 17.10 19.77 13.49
Oct 19.82 18.38 21.54 14.69
Nov 19.26 18.00 21.21 15.13
Dec 16.76 15.84 17.58 9.88

Castle Biosciences information and performance

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization: 476 393 000 $

Market capitalization of the Castle Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CSTL shares in the company outstanding by the market price of one share.

EBITDA: 28 634 000 $

EBITDA of Castle Biosciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.19

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.926
Quarterly Revenue Growth YOY: 0.206
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.654

Enterprise Value (EV) /Revenue

EV To EBITDA: 5.57

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 28872300

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Castle Biosciences Stock)

Should I Buy Castle Biosciences Shares in 2025 year?

The maximum forecasted share price for next year is $18.25, which is $2.15 higher than the current stock price. By investing in Castle Biosciences shares today for a one-year period, you could achieve a profit of 13.34%. With an investment horizon of up to two years, the target share price is $19.82. resulting in a profit of 23.10% ($3.72 per share).

Does Castle Biosciences pay dividends?

No, it does not

Which economic sector do Castle Biosciences's shares belong to?

Castle Biosciences's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Castle Biosciences's shares?

You can view all the stocks that are part of the same sector as Castle Biosciences's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.